Omega Fund Management as of June 30, 2025
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 13 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beta Bionics Common Stock (BBNX) | 18.7 | $29M | 2.0M | 14.56 | |
| Kestra Med Technologies Common Stock (KMTS) | 17.7 | $27M | 1.6M | 16.58 | |
| Upstream Bio Common Stock (UPB) | 14.5 | $22M | 2.0M | 10.98 | |
| Nuvation Bio Common Stock Class A (NUVB) | 13.9 | $22M | 11M | 1.95 | |
| Bicara Therapeutics Common Stock (BCAX) | 13.3 | $21M | 2.2M | 9.29 | |
| Replimune Group Common Stock (REPL) | 11.9 | $18M | 2.0M | 9.29 | |
| Lexeo Therapeutics Common Stock (LXEO) | 3.1 | $4.8M | 1.2M | 4.02 | |
| Ikena Oncology Common Stock (IKNA) | 2.0 | $3.0M | 2.2M | 1.34 | |
| Sana Biotechnology Common Stock (SANA) | 1.5 | $2.3M | 844k | 2.73 | |
| Alumis Common Stock (ALMS) | 1.3 | $2.0M | 653k | 3.00 | |
| enGene Holdings Common Stock (ENGN) | 1.2 | $1.9M | 526k | 3.64 | |
| Immunic Common Stock (IMUX) | 0.8 | $1.2M | 1.8M | 0.70 | |
| enGene Holdings Warrant (ENGNW) | 0.2 | $273k | 322k | 0.85 |
